Detalhe da pesquisa
1.
Risk-reducing mastectomy and breast cancer mortality in women with a BRCA1 or BRCA2 pathogenic variant: an international analysis.
Br J Cancer
; 130(2): 269-274, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030749
2.
Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
N Engl J Med
; 385(5): 395-405, 2021 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320285
3.
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Breast Cancer Res Treat
; 205(2): 227-239, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38273214
4.
Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium.
Breast Cancer Res
; 25(1): 72, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37340476
5.
Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation.
Breast Cancer Res Treat
; 201(2): 257-264, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432545
6.
Trends in use of neoadjuvant systemic therapy in patients with clinically node-positive breast cancer in Europe: prospective TAXIS study (OPBC-03, SAKK 23/16, IBCSG 57-18, ABCSG-53, GBG 101).
Breast Cancer Res Treat
; 201(2): 215-225, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355526
7.
Neoadjuvant Therapy and Axillary Lymph Node Status in HER2-Positive Breast Cancer.
Cancer Invest
; 41(6): 593-600, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37462505
8.
Residual fibroglandular breast tissue after mastectomy is associated with an increased risk of a local recurrence or a new primary breast cancer".
BMC Cancer
; 23(1): 281, 2023 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36978031
9.
Clinical, splicing, and functional analysis to classify BRCA2 exon 3 variants: Application of a points-based ACMG/AMP approach.
Hum Mutat
; 43(12): 1921-1944, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979650
10.
Oral Abundance of Actinomyces spp. in Breast Cancer Patients.
Oncology
; 100(4): 221-227, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051923
11.
Atezolizumab plus nab-paclitaxel for unresectable, locally advanced or metastatic breast cancer: real-world results from a single academic center in Austria.
BMC Cancer
; 22(1): 1099, 2022 Oct 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289467
12.
Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol
; 164(3): 514-521, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35063280
13.
A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN-inactivating mutations.
Future Oncol
; 18(30): 3377-3387, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36039910
14.
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.
Br J Cancer
; 124(11): 1795-1802, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33762716
15.
Tissue Sodium Concentration Quantification at 7.0-T MRI as an Early Marker for Chemotherapy Response in Breast Cancer: A Feasibility Study.
Radiology
; 299(1): 63-72, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33591888
16.
Oral contraceptive use and ovarian cancer risk for BRCA1/2 mutation carriers: an international cohort study.
Am J Obstet Gynecol
; 225(1): 51.e1-51.e17, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493488
17.
Expression of COX-2, p16, and Ki67 in the range from normal breast tissue to breast cancer.
Neoplasma
; 68(2): 342-351, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33147051
18.
Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res
; 22(1): 8, 2020 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31948486
19.
Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res
; 22(1): 25, 2020 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32102695
20.
Breastfeeding and the risk of epithelial ovarian cancer among women with a BRCA1 or BRCA2 mutation.
Gynecol Oncol
; 159(3): 820-826, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33010967